A CLINICAL STUDY TO EVALUATE THE BENEFITS OF ANKOLADI VATI AND NISHAMALAKI VATI ALONG WITH STANDARD TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

AN OPEN LABEL RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF ANKOLADI VATI AND NISHAMALAKI VATI AS AN ADJUVANT TO STANDARD CARE IN MADHUMEHA vis a vis TYPE 2 DIABETES MELLITUS - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112808

Enrollment

Registered

2026-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling the objective criteria 2.Subjects receiving standard care for Type 2 Diabetes Mellitus ((T2DM). 3.Written consent showing willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Subjects having severe systemic diseases like Cardiac disease, Renal function impairment, Pulmonary Tuberculosis, Liver disorders. 2.Subjects suffering from complications of Diabetes like Ketoacidosis,Nephropathy and Diabetic wounds. 3.Subjects suffering from Insulin Dependent Diabetes Mellitus (IDDM). 4.Known case of any active malignancy. 5.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Ankoladi Vati and Nishamalaki Vati as an adjuvant to Standard Care in Madhumeha vis- -vis Type 2 Diabetes Mellitus (T2DM).Timepoint: Pre test - Oth day Mid test -31st day Mid test -61st day Post test - 91st day	—

Secondary

Measure	Time frame
To evaluate the efficacy of Ankoladi Vati as an adjuvant to Standard Care in Madhumeha vis- -vis Type 2 Diabetes Mellitus (T2DM).Timepoint: Pre test - Oth day Mid test -31st day Mid test -61st day Post test - 91st day;To evaluate the efficacy of Nishamalaki Vati as an adjuvant to Standard Care in Madhumeha vis- -vis Type 2 Diabetes Mellitus (T2DM).Timepoint: Pre test - Oth day Mid test -31st day Mid test -61st day Post test - 91st day	—

Measure

Time frame

To evaluate the efficacy of Ankoladi Vati as an adjuvant to Standard Care in Madhumeha vis- -vis Type 2 Diabetes Mellitus (T2DM).Timepoint: Pre test - Oth day Mid test -31st day Mid test -61st day Post test - 91st day;To evaluate the efficacy of Nishamalaki Vati as an adjuvant to Standard Care in Madhumeha vis- -vis Type 2 Diabetes Mellitus (T2DM).Timepoint: Pre test - Oth day Mid test -31st day Mid test -61st day Post test - 91st day

—

Countries

India

Contacts

Public ContactDr Darade Nikita Nivritti

JSS Ayurveda Medical College and Hospital

deepsmysore@gmail.com9886485005

Outcome results